Polypharmacy in Gerontology
Cassandra Rodocker, Lauren Scarponi, Jessica Talbot, Lisa Tripp
Polypharmacy:
The concurrent use of
multiple medications
(Mauk, 2014, p417)
The problem:
Polypharmacy increases
the risk of morbidity and
mortality
30%
50%
41%
Clients that have 2 or more
physicians; resulting in
polypharmacy
Clients that are prescribed 5
or more medications
65 year olds admitted to
hospital because of
polypharmacy
Physiological Effects on Older Adults
Nonspecific Complaints (i.e. cognitive
impairment, falls, decreased functional status,
malaise, abdominal discomfort, nausea/vomiting,
sleep changes, fatigue/weakness) caused by
drug-drug interactions
food-drug interactions
disease-drug interactions
drug toxicity
Increased morbidity and mortality
The solution
Education and Documentation
Clients should be
encouraged to inform all of
their doctors of all of their
medications (or preferably,
see only one doctor)
Nurses and doctors should
teach clients about what
medications do, so clients
can advocate for themselves
BEERS A Clinical Tool for Nurses
How it works: Beers catalogues medications that cause adverse drug events
Step 1
Inappropriate drug choice
Medications generally to
be avoided in the elderly
population
Step 2
Excess dosage
Medications at a dose or
duration of therapy not to
be exceeded
Step 3
Drug-disease interaction
Medications to be
avoided for patients with
specific co-morbid
conditions
Category One: Inappropriate drug choice
Therapeutic/ Category Drug
Long-acting benzodiazepines,
including:
diazepam (VALIUM)
flurazepam (DALMANE)
chlordiazepoxide
(LIBRIUM)
*all of which have long
half-lives
Recommendation
AVOID
Rationale
This can lead to
accumulation of the drug,
leading to excessive
sedation and an increase in
the risk of falls and fractures
Category Two: Excess Dosage
Therapeutic/ Category Drug
Long-term use of stimulant
laxatives
bisacodyl (DULCOLAX)
cascara sagrada
(made from the dried
bark of an American
buckthorn)
Recommendation
AVOID
may be appropriate in the
presence of opiate
analgesic use
Rationale
Medication may exacerbate
bowel dysfunction
Category Three: Drug-disease interaction
Therapeutic/ Category Drug
Pts with a hx of syncope
(temporary loss of consciousness
caused by a fall in BP) or falls
receiving meds such as
benzodiazepines and/or
tricyclic antidepressants
amitriptyline (ELAVIL)
doxepin (SINEQUAN)
imipramine (NORPRAMIN)
Recommendation
AVOID
Rationale
Medications may:
Produce ataxia
Impair psychomotor
function
Increase falls
Why do nurses need BEERS?
Nurses are the only members of the healthcare team
that actually witness the client’s use and outcome of
medications
It is our job to advocate for our clients
BEERS will help bridge the knowledge gap for clients
about medications
Nursing Care Plan
Assessment
Assess the patient for
signs/symptoms of
polypharmacy, review and
reconcile patient medication
lists, clarify the purpose and
use of all medications.
Diagnosis
Drug toxicity/drug interaction
r/t concurrent use of multiple
medications manifested by
cognitive/functional
impairment, falls, malaise,
abdominal complaints, etc.
Plan
Goal
Patient will discontinue use
of multiple concurrent
medications and be actively
involved in the process.
Nursing Care Plan
Intervention
Educate the client about the
active ingredients in their
medications and additive
effects of taking multiple
meds with the same active
ingredients
Educate the client about only
using one pharmacy and
taking medications exactly
as prescribed
Educate the client about
lifestyle changes that
could ultimately eliminate
the use of a drug
Educate the client about the
importance of reporting all
medications to all doctors
they visit
Educate the client and family
about the signs of trouble
(see physiological signs of
polypharmacy) and that such
symptoms should be
reported to their doctors
immediately.
Ask the patient to perform
teach-back education:
How they will take their
medications
When they should take
their medications (and
in what doses)
Signs/symptoms of
interactions and
toxicity
Evaluation
References
American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.
(2012). Journal of the American Geriatrics Society, 616-631.
Fusco D., Lattanzio F., Tosato M., Corsonello A., Cherubini A., Volpato S, et al. (2009). Development of CRIteria to
assess appropriate Medication use among Elderly complex patients. (CRIME) Project. Drugs Aging; 26 (Suppl.
1):S3–13.
Kinsella K., Phillips D.R. (2005). Global aging: the challenge of success. Popul Bull; 60:3–42.
Mauk, K. (2014). Gerontological nursing (3rd ed.). Sudbury, MA: Jones and Bartlett Publishers.

Polypharm presentation

  • 1.
    Polypharmacy in Gerontology CassandraRodocker, Lauren Scarponi, Jessica Talbot, Lisa Tripp
  • 2.
    Polypharmacy: The concurrent useof multiple medications (Mauk, 2014, p417)
  • 3.
    The problem: Polypharmacy increases therisk of morbidity and mortality 30% 50% 41% Clients that have 2 or more physicians; resulting in polypharmacy Clients that are prescribed 5 or more medications 65 year olds admitted to hospital because of polypharmacy
  • 4.
    Physiological Effects onOlder Adults Nonspecific Complaints (i.e. cognitive impairment, falls, decreased functional status, malaise, abdominal discomfort, nausea/vomiting, sleep changes, fatigue/weakness) caused by drug-drug interactions food-drug interactions disease-drug interactions drug toxicity Increased morbidity and mortality
  • 5.
    The solution Education andDocumentation Clients should be encouraged to inform all of their doctors of all of their medications (or preferably, see only one doctor) Nurses and doctors should teach clients about what medications do, so clients can advocate for themselves
  • 6.
    BEERS A ClinicalTool for Nurses
  • 7.
    How it works:Beers catalogues medications that cause adverse drug events Step 1 Inappropriate drug choice Medications generally to be avoided in the elderly population Step 2 Excess dosage Medications at a dose or duration of therapy not to be exceeded Step 3 Drug-disease interaction Medications to be avoided for patients with specific co-morbid conditions
  • 8.
    Category One: Inappropriatedrug choice Therapeutic/ Category Drug Long-acting benzodiazepines, including: diazepam (VALIUM) flurazepam (DALMANE) chlordiazepoxide (LIBRIUM) *all of which have long half-lives Recommendation AVOID Rationale This can lead to accumulation of the drug, leading to excessive sedation and an increase in the risk of falls and fractures
  • 9.
    Category Two: ExcessDosage Therapeutic/ Category Drug Long-term use of stimulant laxatives bisacodyl (DULCOLAX) cascara sagrada (made from the dried bark of an American buckthorn) Recommendation AVOID may be appropriate in the presence of opiate analgesic use Rationale Medication may exacerbate bowel dysfunction
  • 10.
    Category Three: Drug-diseaseinteraction Therapeutic/ Category Drug Pts with a hx of syncope (temporary loss of consciousness caused by a fall in BP) or falls receiving meds such as benzodiazepines and/or tricyclic antidepressants amitriptyline (ELAVIL) doxepin (SINEQUAN) imipramine (NORPRAMIN) Recommendation AVOID Rationale Medications may: Produce ataxia Impair psychomotor function Increase falls
  • 11.
    Why do nursesneed BEERS? Nurses are the only members of the healthcare team that actually witness the client’s use and outcome of medications It is our job to advocate for our clients BEERS will help bridge the knowledge gap for clients about medications
  • 12.
    Nursing Care Plan Assessment Assessthe patient for signs/symptoms of polypharmacy, review and reconcile patient medication lists, clarify the purpose and use of all medications. Diagnosis Drug toxicity/drug interaction r/t concurrent use of multiple medications manifested by cognitive/functional impairment, falls, malaise, abdominal complaints, etc. Plan Goal Patient will discontinue use of multiple concurrent medications and be actively involved in the process.
  • 13.
    Nursing Care Plan Intervention Educatethe client about the active ingredients in their medications and additive effects of taking multiple meds with the same active ingredients Educate the client about only using one pharmacy and taking medications exactly as prescribed Educate the client about lifestyle changes that could ultimately eliminate the use of a drug Educate the client about the importance of reporting all medications to all doctors they visit Educate the client and family about the signs of trouble (see physiological signs of polypharmacy) and that such symptoms should be reported to their doctors immediately. Ask the patient to perform teach-back education: How they will take their medications When they should take their medications (and in what doses) Signs/symptoms of interactions and toxicity Evaluation
  • 14.
    References American Geriatrics SocietyUpdated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. (2012). Journal of the American Geriatrics Society, 616-631. Fusco D., Lattanzio F., Tosato M., Corsonello A., Cherubini A., Volpato S, et al. (2009). Development of CRIteria to assess appropriate Medication use among Elderly complex patients. (CRIME) Project. Drugs Aging; 26 (Suppl. 1):S3–13. Kinsella K., Phillips D.R. (2005). Global aging: the challenge of success. Popul Bull; 60:3–42. Mauk, K. (2014). Gerontological nursing (3rd ed.). Sudbury, MA: Jones and Bartlett Publishers.

Editor's Notes

  • #3 *Lauren
  • #4 *Lauren
  • #5 *Lisa
  • #6 *Lisa
  • #8 *Cass step 1: the far left column lists therapeutic categories of drugs and the drugs that fall within them step 2: the recommendation for the drug is listed (for example, do not take drug “A” in dose “X” if you have the condition “B” step 3: rationale for the recommendation is given (for example, the drug may cause toxicity)
  • #9 *Cass step 1: the far left column lists therapeutic categories of drugs and the drugs that fall within them step 2: the recommendation for the drug is listed (for example, do not take drug “A” in dose “X” if you have the condition “B” step 3: rationale for the recommendation is given (for example, the drug may cause toxicity)
  • #10 *Cass step 1: the far left column lists therapeutic categories of drugs and the drugs that fall within them step 2: the recommendation for the drug is listed (for example, do not take drug “A” in dose “X” if you have the condition “B” step 3: rationale for the recommendation is given (for example, the drug may cause toxicity)
  • #11 *Cass step 1: the far left column lists therapeutic categories of drugs and the drugs that fall within them step 2: the recommendation for the drug is listed (for example, do not take drug “A” in dose “X” if you have the condition “B” step 3: rationale for the recommendation is given (for example, the drug may cause toxicity)
  • #12 *Cass
  • #13 *Jess not sure if this is what we’re looking for... Assessment- assess the patient for signs listed in slide 4, review and reconcile patient med lists diagnosis - drug toxicity/drug interaction r/t concurrent use of multiple medications m/b symptoms on slide 4 planning - goal is that the patient will not take multiple concurrent medications intervention - educate the client about the active ingredients in their medications and additive effects of taking multiple meds with the same active ingredients, educate the client about only using one pharmacy, educate the client about taking medications exactly as prescribed, educate the client about the importance of reporting all medications to all doctors they visit, educate the client about the signs of trouble (see slide 4) and that such symptoms should be reported to their doctors immediately evaluation - ask the patient to perform teach-back education about how/when they will take their meds and in what doses, what the signs/symptoms of interactions and toxicity are, etc.
  • #14 *Jess not sure if this is what we’re looking for... Assessment- assess the patient for signs listed in slide 4, review and reconcile patient med lists diagnosis - drug toxicity/drug interaction r/t concurrent use of multiple medications m/b symptoms on slide 4 planning - goal is that the patient will not take multiple concurrent medications intervention - educate the client about the active ingredients in their medications and additive effects of taking multiple meds with the same active ingredients, educate the client about only using one pharmacy, educate the client about taking medications exactly as prescribed, educate the client about the importance of reporting all medications to all doctors they visit, educate the client about the signs of trouble (see slide 4) and that such symptoms should be reported to their doctors immediately evaluation - ask the patient to perform teach-back education about how/when they will take their meds and in what doses, what the signs/symptoms of interactions and toxicity are, etc.